Leverage Shares 2X Long FIX Daily ETF (BATS:FIXX) CFO Sells $10,824.32 in Stock

Leverage Shares 2X Long FIX Daily ETF (BATS:FIXX) CFO Lee Kalowski sold 1,301 shares of the company’s stock in a transaction dated Tuesday, October 6th. The stock was sold at an average price of $8.32, for a total value of $10,824.32. Following the completion of the transaction, the chief financial officer owned 137,170 shares in the company, valued at $1,141,254.40. This represents a 0.94% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this link. The sale was made to cover tax withholding obligations related to the vesting of equity awards.

Lee Kalowski also recently made the following trade(s):

• On Tuesday, August 25th, Lee Kalowski sold 3,972 shares of Leverage Shares 2X Long FIX Daily ETF stock. The shares were sold at an average price of $16.56, for a total value of $65,776.32.

Leverage Shares 2X Long FIX Daily ETF Trading Down 7.1%

Shares of FIXX traded down $0.73 during trading hours on Friday, reaching $9.56. 254 shares of the company’s stock traded hands, compared to its average volume of 2,977. Leverage Shares 2X Long FIX Daily ETF has a 12 month low of $9.14 and a 12 month high of $15.92.

Homology Medicines, Inc was a clinical-stage biotechnology company focused on developing genetic medicines for patients with rare diseases. The company sought to use its proprietary human-derived adeno-associated virus vectors, known as AAVHSCs, to deliver gene therapies in vivo and address the underlying causes of inherited disorders.

Its development programs included HMI-103, an investigational gene therapy for phenylketonuria, as well as earlier programs targeting other rare diseases.